Device used to treat Ebola patient; Harvard to focus on devices and diagnostics;

@FierceMedDev: Who are today's leading women in med tech? Check out our top women in medical devices list to find out. Special report | Follow @FierceMedDev

@VarunSaxena2: Invitae raises $120M to offer cheap, easy genetic analysis. Story | Follow @VarunSaxena2

@EmilyWFierce: $COV recalled some defibrillator electrodes made by $PHG. Story from MassDevice | Follow @EmilyWFierce

@MichaelGFierce: Stem cell-derived beta cells deliver insulin in response to blood sugar levels. Story | Follow @MichaelGFierce

> For the first time, Aethlon Medical used its Hemopurifier therapy on a patient infected with the Ebola virus. Release

> Harvard's Medical and Business schools put developing news device and diagnostics at the top of its list of the Deans' Health & Life Sciences Challenge. More

> Viewics, a CA-based startup, received $8 million in a funding round led by Canvas Venture Fund to use toward controlling hospitals' lab test costs. Story

Biotech News

@FierceBiotech: Meet some of the revolutionaries in biotech R&D. Report | Follow @FierceBiotech

@JohnCFierce: AbbVie to Shire: Maybe we should reconsider that $54B merger deal after all - $SHPG down 27%. Article | Follow @JohnCFierce

@DamianFierce: Fantastically timed press release: "Shire Announces the Organize Your Stuff Contest Winners." Release | Follow @DamianFierce

@EmilyMFierce: These 10 drugs could stop Ebola. Feature | Follow @EmilyMFierce

> Selecta banks $20M for trial work, inks a pact with Sanofi on diabetes. Story

> Forward Pharma pulls off a $221M IPO with eyes on unseating Biogen. More

> DNAtrix pockets $20M to get its cancer-fighting virus into Phase III. Article

Pharma News

@FiercePharma: Our newest special report is live! The top 10 most expensive drugs of 2013. Feature | Follow @FiercePharma

@EricPFierce: Novartis says construction delay of Russian plant no big deal, technical changes and not tied to sanctions. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Sanofi wins kudos for airing bribery probe. Phase II? Take to social media. Article | Follow @CarlyHFierce

> FDA grants a combo-med exclusivity wish. Why is that a problem? Story

> Former finance analyst charged in insider trading case. News

> AbbVie-Shire deal in jeopardy, but not necessarily dead. More

Drug Delivery News

> Robert Langer talks science, business and how they intersect. More

> Stem cell-derived beta cells deliver insulin in response to blood sugar levels. Story

> Stealthy, DNA-based 'nano-cocoons' deliver cancer-killing payloads. Report

> Alnylam releases data on its Phase II study of TTR-mediated amyloidosis patients. Item

> Intersect ENT says latest data on dissolving implants for chronic sinusitis are encouraging. Article

Diagnostics News

> Gene sequencing helps Northwestern team diagnose one cause of epilepsy. More

> Exact Sciences nails coveted Medicare coverage for colon cancer DNA test. News

> SomaLogic, CO hospital to develop biomarkers/Dx tests for childhood diseases. Story

> British startup finishes quick and easy Ebola test. Report

> Biocept, Rosetta Genomics want to beef up Dx and biomarker-detection power. Article

Pharma Marketing News

> Teva's SCOTUS appeal is here. But how much can the outcome really affect Copaxone's market share? More

> World's best CEOs? Gilead, Allergan, Novo and Valeant make top 10. Read

> Looking 'beyond the pill'? Start with an app--and then follow this to-do list. Story

> Can Amgen's marketing muscle vault its Humira biosim ahead of rivals? More

> Pictures tell the story in AstraZeneca's breast cancer photo-sharing push. Article

Suggested Articles

The FDA disclosed over 60 safety reports related to intra-aortic balloon pumps manufactured by Maquet and Datascope, following a recall this summer.

Truvian Sciences raised $27.1 million to fuel the development of its benchtop blood tester, bringing the company’s total funding to $46.3 million.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.